Volume | 117,699 |
|
|||||
News | - | ||||||
Day High | 0.79 | Low High |
|||||
Day Low | 0.730101 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cardio Diagnostics Holdings Inc | CDIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.75 | 0.730101 | 0.79 | 0.75 | 0.7515 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
643 | 117,699 | $ 0.7572772 | $ 89,131 | - | 0.171 - 3.56 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:07 | 90 | $ 0.75 | USD |
Cardio Diagnostics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.18M | 20.52M | - | 17k | -8.38M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cardio Diagnostics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.01 | 1.09 | 0.730101 | 0.8150657 | 404,663 | -0.26 | -25.74% |
1 Month | 1.32 | 1.50 | 0.730101 | 1.04 | 332,901 | -0.57 | -43.18% |
3 Months | 2.13 | 2.40 | 0.730101 | 1.60 | 489,647 | -1.38 | -64.79% |
6 Months | 0.212 | 3.56 | 0.171 | 1.36 | 7,493,654 | 0.538 | 253.77% |
1 Year | 2.53 | 3.56 | 0.171 | 1.33 | 3,921,848 | -1.78 | -70.36% |
3 Years | 4.25 | 8.4999 | 0.171 | 2.05 | 3,317,977 | -3.50 | -82.35% |
5 Years | 4.25 | 8.4999 | 0.171 | 2.05 | 3,317,977 | -3.50 | -82.35% |
Cardio Diagnostics Description
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. |